Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > Flad

<< Previous

Bullboard Posts

Next >>

Comment by flad101on Feb 02, 2021 9:29pm

128 Views

Post# 32454787

RE:RE:RE:Flad

Like I said. I'm not worried. If labs is smart they will take the hit now vs the future. They are already in the doghouse. Take all the write downs get the Hexo receivable off the books and clean the slate. It will be a tough hit but should be done while they have cash.

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments